[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![GSK plc Graphic](https://lunarcrush.com/gi/w:26/t:gsk-plc.png) GSK plc (GSK)

GSK's Shingrix vaccine receives approval in China, but concerns about autism treatment and FDA interference are circulating, impacting market sentiment.

### About GSK plc
GSK plc (GSK) is a healthcare company, with a focus on pharmaceuticals and vaccines.  
GSK plc uses the ticker $GSK for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/gsk-plc/insights)
- GSK plc (GSK) social dominance is up XXXXXXXX% from the previous week.
- GSK plc (GSK) galaxy score™ is up XXXXX% from the previous week.
- GSK plc (GSK) engagements is up XX% from the previous month.
- GSK plc (GSK) posts created is up XXXXX% from the previous year.

### Price: $XXXXX [#](/topic/gsk-plc/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/close.tsv)  
The stock is trading at $40.30, with a slight positive 24-hour change of 0.17%. The positive price movement is likely due to the news of the new CEO and the company's investment plans, but the overall market sentiment appears mixed due to concerns about the autism treatment.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| XXXX%   | XXXX% | XXXX%  |

**1-Year High**: $XXXXX on 2025-10-01  
**1-Year Low**: $XXXXX on 2025-01-14  
  
  
### AltRank: XXX [#](/topic/gsk-plc/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/alt_rank.tsv)  
GSK plc (GSK) is currently AltRank #271 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +382  
**1 Month**: XXX -XX  
**6 Months**: XXX -XXXXX  
**1 Year**: XXX -XXX  
**1-Year High**: XXXXX on 2024-11-11  
**1-Year Low**: X on 2025-02-09  
  
  
### Galaxy Score: XXXXX [#](/topic/gsk-plc/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +14  
**1 Month**: XX -X  
**6 Months**: XX -XX  
**1 Year**: XX +4  
**1-Year High**: XX on 2025-05-13  
**1-Year Low**: XX on 2025-07-03  
  
  
### Engagements: XXXXX [#](/topic/gsk-plc/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX +63%  
**1 Month**: XXXXXXX +87%  
**6 Months**: XXXXXXXXX +0.07%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2024-12-05  
**1-Year Low**: XXX on 2025-04-20  

| Social Network | X     | YouTube | News |
| -------------- | -     | ------- | ---- |
| Engagements    | XXXXX | XXX     | X    |
  

  
  
### Mentions: XXX [#](/topic/gsk-plc/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +47%  
**1 Year**: XXXXX +104%  
**1-Year High**: XXX on 2025-08-03  
**1-Year Low**: XX on 2025-09-15  

| Social Network | X   | YouTube | News |
| -------------- | -   | ------- | ---- |
| Mentions       | XXX | X       | X    |
  

  
  
### Creators: XX [#](/topic/gsk-plc/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning GSK plc (GSK) in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XXX +20%  
**6 Months**: XXXXX +51%  
**1 Year**: XXXXX +95%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2025-09-15  

The most influential creators that mention GSK plc in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | X    | XXXXXX    | X     | XXXXX       |
| [@Quantumup1](/creator/twitter/Quantumup1)           | X    | XXXXX     | X     | XX          |
| [@SamFazeli8](/creator/twitter/SamFazeli8)           | X    | XXXXX     | X     | XX          |
| [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | X    | XXXXX     | X     | XX          |
| [@NemoThematic](/creator/twitter/NemoThematic)       | X    | XX        | X     | XX          |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | X    | XXXXX     | X     | XX          |
| [@herostick](/creator/twitter/herostick)             | X    | XXX       | X     | XX          |
| [@HenriettaBrid19](/creator/twitter/HenriettaBrid19) | X    | XXX       | XX    | XX          |
| [@Capitol_Forum](/creator/twitter/Capitol_Forum)     | X    | XXXXX     | X     | XX          |
| [@financebully](/creator/twitter/financebully)       | XX   | XXX       | X     | XX          |

[View More](/list/creators/gsk-plc/100)
  
  
### Sentiment: XX% [#](/topic/gsk-plc/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -X%  
**1-Year High**: XXX% on 2025-03-21  
**1-Year Low**: XX% on 2025-08-25  

**Most Supportive Themes**
- **Big Pharma Investment and Expansion:** (30%) GSK's investment in US manufacturing and R&D, along with similar moves by other pharmaceutical companies, is a supportive theme.
- **Positive Sentiment on GSK's Actions:** (20%) Posts highlighting GSK's plans to invest in the US market and adapt to trade policies are generally supportive.
  
**Most Critical Themes**
- **Concerns about Autism Treatment:** (40%)  Discussions surrounding GSK's leucovorin drug and its potential link to autism, fueled by political figures, are critical.
- **General Market Speculation:** (10%)  Many posts are simply lists of stocks with little analysis, which can be seen as critical due to lack of substance.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
| YouTube | XX       | X%  | XX      | X%  | X        | X% |
| News    | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/gsk-plc/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXX% +0.037%  
**1 Month**: XXXXX% -XXXXXX%  
**6 Months**: XXXXX% -XXXXXX%  
**1 Year**: XXXXX% -XXXXX%  
**1-Year High**: XXXXX% on 2024-11-27  
**1-Year Low**: XXXXXX% on 2025-09-15  
  
  
### Market Dominance: XXXXX% [#](/topic/gsk-plc/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXX% on 2025-03-31  
**1-Year Low**: XXXXX% on 2024-12-16  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/gsk-plc/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX +$1.60%  
**1 Month**: $XXXXXXXXXXXXXX +$7.90%  
**6 Months**: $XXXXXXXXXXXXXX +$19%  
**1 Year**: $XXXXXXXXXXXXXX +$12%  
**1-Year High**: $XXXXXXXXXXXXXX on 2025-10-01  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-01-14  

**Top assets mentioned**
In the posts about GSK plc in the last XX hours

[GSK plc (GSK)](/topic/$gsk)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Novo-Nordisk (NVO)](/topic/$nvo)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[AstraZeneca PLC (AZN)](/topic/$azn)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[AbbVie Inc (ABBV)](/topic/$abbv)
[Bristol-Myers Squibb Co (BMY)](/topic/$bmy)
[Sanofi (SNY)](/topic/sanofi)

**Top topics mentioned**
In the posts about GSK plc in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$pfe](/topic/$pfe), [$nvo](/topic/$nvo), [$mrk](/topic/$mrk), [$azn](/topic/$azn), [stocks technology](/topic/stocks-technology), [stocks financial services](/topic/stocks-financial-services), [$scyx](/topic/$scyx), [$amgn](/topic/$amgn), [$abbv](/topic/$abbv), [$bmy](/topic/$bmy), [stocks banks](/topic/stocks-banks), [sanofi](/topic/sanofi), [stocks](/topic/stocks), [approved](/topic/approved), [eli lilly](/topic/eli-lilly), [$rhhby](/topic/$rhhby), [white house](/topic/white-house), [investment](/topic/investment), [$spro](/topic/$spro), [$xbi](/topic/$xbi), [over the](/topic/over-the), [china](/topic/china), [stocks consumer defensive](/topic/stocks-consumer-defensive), [tariffs](/topic/tariffs), [stocks industrials](/topic/stocks-industrials), [$itw](/topic/$itw), [$intc](/topic/$intc), [$elan](/topic/$elan), [$amrx](/topic/$amrx), [$mdgl](/topic/$mdgl), [$alec](/topic/$alec), [$akro](/topic/$akro), [$lly](/topic/$lly), [emma](/topic/emma), [$rog](/topic/$rog), [$tmo](/topic/$tmo), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [rfk](/topic/rfk), [wall street](/topic/wall-street), [nasdaq](/topic/nasdaq), [anita](/topic/anita), [$itub](/topic/$itub), [he will](/topic/he-will), [has been](/topic/has-been), [$psnl](/topic/$psnl), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$dvax](/topic/$dvax), [$idya](/topic/$idya), [combo](/topic/combo), [$iron](/topic/$iron), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks communication services](/topic/stocks-communication-services), [coins defi](/topic/coins-defi), [$gkos](/topic/$gkos), [$mpw](/topic/$mpw), [$ebc](/topic/$ebc), [coins gaming](/topic/coins-gaming), [$ci](/topic/$ci), [gilead sciences](/topic/gilead-sciences), [$jazz](/topic/$jazz), [donald trump](/topic/donald-trump), [$hikl](/topic/$hikl), [tesla](/topic/tesla), [money](/topic/money), [$rdgl](/topic/$rdgl), [biogen inc](/topic/biogen-inc), [breaking news](/topic/breaking-news), [$dhr](/topic/$dhr), [$sny](/topic/$sny), [$etnb](/topic/$etnb), [$35b](/topic/$35b), [trumps](/topic/trumps), [live now](/topic/live-now), [6 months](/topic/6-months), [$issc](/topic/$issc), [dividend yield](/topic/dividend-yield), [drift](/topic/drift), [momentum](/topic/momentum), [$25m](/topic/$25m), [$30m](/topic/$30m), [investments](/topic/investments), [boston](/topic/boston), [$220b](/topic/$220b), [$oklo](/topic/$oklo), [$wve](/topic/$wve), [$beams](/topic/$beams), [$200m](/topic/$200m), [$128k](/topic/$128k), [jacob](/topic/jacob), [rescue](/topic/rescue), [$nvax](/topic/$nvax), [salesforce](/topic/salesforce), [$60b](/topic/$60b), [$pph](/topic/$pph), [johnson johnson](/topic/johnson-johnson), [$jnj](/topic/$jnj), [acquisition](/topic/acquisition), [success rate](/topic/success-rate), [imo](/topic/imo)

### Top Social Posts [#](/topic/gsk-plc/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Big Pharma bets big on MASH with a new combo playbook GSK Roche and Novo jumped into MASH with a multi-billion-dollar deal spree. Now the phase X data have to deliver $GSK $RHHBY $NVO #pharma #MASH"  
[X Link](https://x.com/Alpha_Bronze/status/1979901597506535484) [@Alpha_Bronze](/creator/x/Alpha_Bronze) 2025-10-19T13:25Z 7554 followers, XXX engagements


"A few drug manufacturing names look good heading into next week $ABBV $AZN $GSK"  
[X Link](https://x.com/DamianALGO_/status/1979671523679215746) [@DamianALGO_](/creator/x/DamianALGO_) 2025-10-18T22:10Z XXX followers, XXX engagements


"@jeromeleonard5 @JoseRestonVA @princetongb i think $gsk would benefit the most from $idya bo. theyre trying to build an onc franchise already have a stake in two programs and can dedicate the resources to rescue their own onc pipeline. expensive for them but nice bookend to idrx jan bo in precision onc"  
[X Link](https://x.com/financebully/status/1979648332051198038) [@financebully](/creator/x/financebully) 2025-10-18T20:38Z XXX followers, XXX engagements


"$XBI A very nice nuanced @FiercePharma piece on the state of MASH therapeutics: $MDGL $NVO $GSK $RHHBY $AKRO $ETNB"  
[X Link](https://x.com/PersimmonTI/status/1979596210710159653) [@PersimmonTI](/creator/x/PersimmonTI) 2025-10-18T17:11Z 10.3K followers, 1714 engagements